Broadly neutralizing antibodies (bNAbs) - dual
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Broadly neutralizing antibodies (bNAbs) - dual, covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control [Phase 2]